Program
pilabactam sodium
Its studies are mostly in Renal Insufficiency, led by Antabio.
Furthest: phase 1, since May 19, 20233 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Antabio | 30 open or running | phase 1since May 19, 2023 | May 19, 2023 | none ahead |
Also a collaborator on its studies: clinartis.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 19, 2023First study: phase 1 study in Healthy VolunteersFirst studyNCT05905913 · 72 enrolled · France
- Jul 8, 2024Phase 1 study in Renal InsufficiencyNCT06527677 · 41 enrolled · Germany
- Apr 2, 2025Phase 1 study in Pharmacokinetics Study on Healthy Volunteers AdultsNCT06916156 · 26 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06916156Pharmacokinetics Study on Healthy Volunteers Adults · United States | 1 | Completed | Aug 14, 2025 | 26 |
| NCT06527677Renal Insufficiency · Germany | 1 | Completed | Jul 3, 2025 | 41 |
| NCT05905913Healthy Volunteers · France | 1 | Completed | Jan 5, 2024 | 72 |
How it is read
Names in the registry
- “ANT3310”, 5 entries
Conditions, from the studies’ own filings
- Renal Insufficiency, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.